Xylem Affirms FY2026 Adj EPS Guidance of $5.55-$5.70 vs $5.54 Est; Affirms FY2026 Sales Guidance of $9.200B vs $9.254B Est
Xylem (NYSE:XYL) affirms FY2026 Adj EPS guidance from $5.55-$5.70 to $5.55-$5.70 vs $5.54 analyst estimate. Affirms FY2026 sales outlook from $9.200 billion to $9.200 billion vs $9.254 billion estimate.
Xylem says it still expects to earn a certain amount of money and make a certain amount of sales next year, and those numbers are pretty close to what experts guessed. When a company sticks with its plans like this, it usually means they feel confident about their business staying on track.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.